These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7457287)

  • 21. Effect of different fractions of dialyzable leukocyte extract--transfer factor--on the chemiluminescence of human phagocytes.
    Sipka S; Schröder I; Brazsnikova NA
    Allergol Immunopathol (Madr); 1987; 15(3):143-4. PubMed ID: 3661353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer factor in diseases of the central nervous system.
    Graybill JR
    Adv Neurol; 1974; 6():107-26. PubMed ID: 4614652
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of transfer factor in patients with advanced cancer.
    Krown SE; Pinsky CM; Hirshaut Y; Hansen JA; Oettgen HF
    Isr J Med Sci; 1978 Oct; 14(10):1026-38. PubMed ID: 310813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
    Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
    Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical analysis of dialyzable leukocyte extracts.
    Gottlieb AA; Saito K; Sutcliffe S; Foster LA; Tamaki N; Maziarz G; Sutherland C; Brennessel B
    J Reticuloendothel Soc; 1977 Jun; 21(6):403-16. PubMed ID: 886545
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
    Grob PJ; Reymond JF; Häcki MA; Frey-Wettstein M
    MMW Munch Med Wochenschr; 1975 Mar; 117(13):517-24. PubMed ID: 805916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oldest survivor with Wiskott-Aldrich syndrome.
    Pritikin RI; Fudenberg HH
    Metab Pediatr Ophthalmol; 1980; 4(3):169-71. PubMed ID: 7453283
    [No Abstract]   [Full Text] [Related]  

  • 29. [Human specific transfer factor to Staphylococcus aureus antigens].
    Liubchenko TA; Holeva OH; Kholodna LS; Stepanchuk VA; Vershyhora AIu
    Fiziol Zh (1994); 1997; 43(3-4):25-32. PubMed ID: 9303798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins.
    Wilson GB; Fudenberg HH; Jonsson HT; Smith CL
    Clin Immunol Immunopathol; 1980 May; 16(1):90-102. PubMed ID: 7379353
    [No Abstract]   [Full Text] [Related]  

  • 31. Nature and activities of transfer factor.
    Petersen EA; Kirkpatrick CH
    Ann N Y Acad Sci; 1979; 332():216-27. PubMed ID: 231399
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transfer factor and its therapeutic use].
    Rosenthal M
    Schweiz Med Wochenschr; 1974 Oct; 104(43):1501-6. PubMed ID: 4549135
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of transfer factor to clinical immunotherapy.
    Greco RS
    Surg Gynecol Obstet; 1976 May; 142(5):765-78. PubMed ID: 772850
    [No Abstract]   [Full Text] [Related]  

  • 34. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor.
    Sellars WA; South MA
    Am J Dis Child; 1975 May; 129(5):622-7. PubMed ID: 806224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
    Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoarticular and chronic mucocutaneous candidiasis.
    Alarcón GS; Patrucco R; Castillo W
    Ala J Med Sci; 1982 Oct; 19(4):368-70. PubMed ID: 7181035
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunomorphological changes in the lymph nodes and spleen of rats sensitized with the transfer factor].
    Chivinda Eduardo AB; Kalynovs'ka IH
    Fiziol Zh (1994); 2000; 46(4):66-70. PubMed ID: 10997302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Discoid" lupus erythematosus: dramatic clinical and immunological response to dialyzable leukocyte extract (transfer factor).
    Fudenberg HH; Strelkauskas AJ; Goust JM; Osborne D; Fort D; Vasily D
    Trans Assoc Am Physicians; 1981; 94():279-91. PubMed ID: 6979820
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review.
    Klesius PH; Fudenberg HH; Smith CL
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):247-60. PubMed ID: 6162606
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transfer factor (its use in immunotherapy of neoplasms and other diseases)].
    Zduńczyk A
    Wiad Lek; 1980 Jun; 33(11):877-81. PubMed ID: 6999743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.